Skip to main content
Market intelligence
BCAXHealthcare

Bicara Therapeutics Inc. insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
May 21, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
May 21, 2026Ivan HyepChief Financial OfficerSale9,200$20.42$187,883
May 18, 2026Claire MazumdarChief Executive OfficerSale15,000$20.04$300,579
May 15, 2026Ryan CohlheppPresident and COOSale12,500$20.29$253,649